Buyer	NHS England — not a council we hold
Supplier	Bio Products Laboratory Ltd
Supplier	CSL Behring UK Ltd
Supplier	LFB
Supplier	Novo Nordisk
Supplier	Octapharma Limited
Supplier	Pfizer Ltd
Supplier	Roche Products Ltd
Supplier	Sobi (Swedish Orphan Biovitrum Ltd)
Supplier	Takeda UK Ltd

Project Title: NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - July 2024 Offer reference number: CM/PHS/22/5661 Period of framework: 1 July 2024 to 30 April 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Runs	1 Jul 2024 to 30 Apr 2027
OCID	ocds-b5fd17-78480ca7-506a-4fbd-ab2d-b535c8904519
Notice	Read it on Contracts Finder

Figures are as published An award value in OCDS may be a framework ceiling rather than a sum anyone expects to spend, so a large figure here is not evidence of a large purchase.